4:35 PM ET
8-K
Capital Raise
Lucid Diagnostics Capital Raise of $15M
Lucid Diagnostics entered into subscription agreements with accredited investors for the private placement of 15,000 shares of newly designated Series C Convertible Preferred Stock. The offering generated aggregate gross proceeds of approximately $15.0 million at a purchase price of $1,000 per share.
- Value
- $15M